US Patent Issued to Hutchmed on April 14 for "Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,713, issued on April 14, was assigned to Hutchmed Ltd. (Shanghai).

"Crystalline forms of 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide" was invented by Zhenping Wu (Shanghai), Wenji Li (Shanghai) and Yuping Chu (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the pharmaceutical field, provides novel crystalline forms, solvates and the crystalline forms thereof of compound 6-((6,7-dimethoxyquinazolin-4-yl)oxy)-N,2-dimethylbenzofuran-3-carboxamide, pharmaceutical compositions, as well as the methods of preparation and the use thereof."

The patent was filed on Feb. 27, 2024, under ...